Imperial Brands PLC Transaction in Own Shares

RNS Number : 8288Q

Imperial Brands PLC

19 December 2024

 

IMPERIAL BRANDS PLC

Legal Entity Identifier (LEI) No. 549300DFVPOB67JL3A42

Transaction in own shares

Imperial Brands PLC (the "Company") announces that on 19 December 2024 it purchased for cancellation the following number of its ordinary shares of 10 pence each pursuant to its GBP 1.25 billion share repurchase programme, details of which were announced on 30 October 2024.

 

Description of shares: Imperial Brands PLC - ordinary shares of 10 pence

Number of shares repurchased: 187,487

Date of transaction: 19 December 2024

Average price paid per share: GBp 2,566.39

Lowest price paid per share: GBp 2,544.00

Highest price paid per share: GBp 2,582.00

Broker: Morgan Stanley & Co. International Plc ("Morgan Stanley")

The Company intends to cancel these Shares.

 

All shares were purchased from Morgan Stanley as an on exchange transaction subject to the rules of the London Stock Exchange.

Following the purchase and subsequent settlement and cancellation of these shares, the remaining number of ordinary shares in issue will be 838,251,306 (excluding treasury shares).

 

The figure of 838,251,306 may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), detailed information about the individual purchases is attached to this announcement.

http://www.rns-pdf.londonstockexchange.com/rns/8288Q_1-2024-12-19.pdf

 

Contacts:

Peter Durman                                                                [phone]

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

POSFLFIDFILALIS